Get started
Author

Catarina Eloy

Observed names: C Eloy, C. Eloy, Eloy, Catarina, Eloy, Catarina Alexandra Pires
Observed institutions: University Health Network, Universidade do Porto, University of Toronto, Hospital de São João, Instituto Português de Oncologia Francisco Gentil, Laboratoire d'Informatique, Signaux et Systèmes de Sophia Antipolis, i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Fundação Ensino e Cultura Fernando Pessoa, Instituto de Investigação Inovação e Desenvolvimento, Centro de Investigação do Instituto Português de Oncologia do Porto Francisco Gentil
ORCID: 0000-0001-7642-1280
Observed ORCID: 0000-0001-7642-1280
OpenAlex ID: A5026672125
Classification of breast cancer histology images using Convolutional Neural Networks
2017 · Teresa Araújo, Guilherme Aresta, et al. · PLoS ONE · 1,019
PDF
BACH: Grand challenge on breast cancer histology images
2019 · Guilherme Aresta, Teresa Araújo, et al. · Medical Image Analysis · 717
PDF
TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas
2014 · Miguel Melo, Adriana Gaspar da Rocha, et al. · The Journal of Clinical Endocrinology & Metabolism · 552
PDF
Follicular thyroid carcinoma
2011 · Manuel Sobrinho-Simões, Catarina Eloy, et al. · Modern Pathology · 174
PDF
Best Practice Recommendations for the Implementation of a Digital Pathology Workflow in the Anatomic Pathology Laboratory by the European Society of Digital and Integrative Pathology (ESDIP)
2021 · Filippo Fraggetta, Vincenzo L’Imperio, et al. · Diagnostics · 130
PDF
Artificial intelligence–assisted cancer diagnosis improves the efficiency of pathologists in prostatic biopsies
2023 · Catarina Eloy, Ana Marques, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 123
PDF
Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade
2023 · M. Alvaro Berbís, David S. McClintock, et al. · EBioMedicine · 121
PDF
Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway
2018 · José Manuel Cameselle-Teijeiro, Diego Peteiro-González, et al. · Modern Pathology · 87
Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
2011 · Paula Soares, Jorge Lima, et al. · Current Genomics · 82
PDF
Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent DICER1 alterations—is the term “thyroblastoma” more appropriate?
2020 · Abbas Agaimy, Leora Witkowski, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 81
PDF
Automatic classification of tissue malignancy for breast carcinoma diagnosis
2018 · Irene Fondón, Auxiliadora Sarmiento, et al. · Computers in Biology and Medicine · 80
NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features
2018 · Catarina Tavares, Maria João Coelho, et al. · Endocrine Connections · 79
PDF
Digital Pathology Workflow Implementation at IPATIMUP
2021 · Catarina Eloy, João Vale, et al. · Diagnostics · 78
PDF
Global impact of the COVID‐19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries
2020 · Elena Vigliar, Rima Cepurnaite, et al. · Cancer Cytopathology · 69
PDF
Real-World Implementation of Digital Pathology: Results From an Intercontinental Survey
2023 · Daniel Gomes Pinto, Andrey Bychkov, et al. · Laboratory Investigation · 61
PDF
HEROHE Challenge: Predicting HER2 Status in Breast Cancer from Hematoxylin–Eosin Whole-Slide Imaging
2022 · Eduardo Conde-Sousa, João Vale, et al. · Journal of Imaging · 58
PDF
Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers
2020 · José Manuel Cameselle-Teijeiro, Catarina Eloy, et al. · Endocrine Pathology · 55
PDF
Digital transformation of pathology - the European Society of Pathology expert opinion paper
2025 · Catarina Eloy, Filippo Fraggetta, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 50
The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases
2011 · Catarina Eloy, Joana Santos, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 50
RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas
2012 · Margriet M de Vries, Ricardo Celestino, et al. · Histopathology · 49
TGF-beta/Smad pathway and BRAF mutation play different roles in circumscribed and infiltrative papillary thyroid carcinoma
2012 · C. Eloy, J. Santos, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 47
Hobnail Variant of Papillary Thyroid Carcinoma
2016 · José M. Cameselle-Teijeiro, Irene Rodríguez-Pérez, et al. · The American Journal of Surgical Pathology · 43
mTOR activation in medullary thyroid carcinoma with RAS mutation
2014 · Joana Lyra, João Vinagre, et al. · European Journal of Endocrinology · 43
Cribriform-Morular Variant of Papillary Thyroid Carcinoma Displaying Poorly Differentiated Features
2013 · Tadao Nakazawa, Ricardo Celestino, et al. · International Journal of Surgical Pathology · 40
Molecular Pathology of Non-familial Follicular Epithelial–Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification
2021 · Paula Soares, Antónia Afonso Póvoa, et al. · Endocrine Pathology · 38
Works count: 175
Citation count: 5,166
H-index: 32
I10-index: 74
Year
Topic
Type